# GLAUKOS Corp (GKOS) FY2026 YTD Q2 P&L / Income Statement

- Company: GLAUKOS Corp (GKOS)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-29, accession number 0001193125-26-324201
- Page: https://plicit.ai/financials/gkos/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/gkos-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2026-01-01 through 2026-06-30. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 336,181,000 US dollars
- **Cost of sales**: 67,355,000 US dollars
- **Gross profit**: 268,826,000 US dollars
- **Total operating expenses**: 305,949,000 US dollars
- **Loss from operations**: negative 37,123,000 US dollars
- **Total non-operating (expense) income**: 103,000 US dollars
- **Loss before taxes**: negative 37,020,000 US dollars
- **Income tax provision**: 1,140,000 US dollars
- **Net loss**: negative 38,160,000 US dollars
- **Corneal Health - UNITED STATES**: 47,081,000 US dollars
- **Corneal Health - International**: 4,660,000 US dollars
- **Glaucoma - UNITED STATES**: 212,002,000 US dollars
- **Glaucoma - International**: 72,438,000 US dollars
- **Acquired in-process research and development**: 1,500,000 US dollars
- **Research and development**: 95,446,000 US dollars
- **Selling, general and administrative**: 209,003,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/gkos/fy2026-ytd-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/gkos-fy2026-ytd-q2-revenue-by-geography-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 336,181,000 US dollars
- **Cost of sales**: 67,355,000 US dollars
- **Gross profit**: 268,826,000 US dollars
- **Total operating expenses**: 305,949,000 US dollars
- **Loss from operations**: negative 37,123,000 US dollars
- **Total non-operating (expense) income**: 103,000 US dollars
- **Loss before taxes**: negative 37,020,000 US dollars
- **Income tax provision**: 1,140,000 US dollars
- **Net loss**: negative 38,160,000 US dollars
- **UNITED STATES**: 259,083,000 US dollars
- **International**: 77,098,000 US dollars
- **Acquired in-process research and development**: 1,500,000 US dollars
- **Research and development**: 95,446,000 US dollars
- **Selling, general and administrative**: 209,003,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service

- Page: https://plicit.ai/financials/gkos/fy2026-ytd-q2-income-statement/revenue-by-product-and-service
- Chart image: https://plicit.ai/charts/gkos-fy2026-ytd-q2-revenue-by-product-and-service-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 336,181,000 US dollars
- **Cost of sales**: 67,355,000 US dollars
- **Gross profit**: 268,826,000 US dollars
- **Total operating expenses**: 305,949,000 US dollars
- **Loss from operations**: negative 37,123,000 US dollars
- **Total non-operating (expense) income**: 103,000 US dollars
- **Loss before taxes**: negative 37,020,000 US dollars
- **Income tax provision**: 1,140,000 US dollars
- **Net loss**: negative 38,160,000 US dollars
- **Glaucoma**: 284,440,000 US dollars
- **Corneal Health**: 51,741,000 US dollars
- **Acquired in-process research and development**: 1,500,000 US dollars
- **Research and development**: 95,446,000 US dollars
- **Selling, general and administrative**: 209,003,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.